• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Should the WHO’s Hemoglobin Threshold for Determining Anemia Be Lower?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • The World Health Organization’s Hb anemia cutoffs, used internationally, are derived from “over 95% of normal individuals are believed to show Hb levels higher than the cutoffs given”
    • Based on a few studies of European and North American populations
    • 11.0 g/dL for children | 12.0 g/dL for nonpregnant women
  • Yaw Addo et al. (JAMA Network Open, 2021) evaluated the current WHO Hb cutoffs for defining anemia and assessed threshold validity using tissue biomarkers along with multinational data

METHODS:

  • Secondary cross-sectional study (2005 to 2016)
    • Data derived from Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project
      • Inclusion: Nonmissing Hb | Inflammation biomarkers | Nutritional biomarker of iron (ferritin or transferrin receptor) or vitamin A (retinol or retinol-binding protein [RBP])
    • 25 countries
    • Population-based nutrition surveys: Preschool children aged 6 to 59 months | Nonpregnant women aged 15 to 49 years
  • Participants
    • Healthy members of the persons present in the above data sets
    • Exclusions
      • Iron deficiency: Ferritin <12 ng/mL for children or <15 ng/mL for women
      • Vitamin A deficiency: Retinol-binding protein or retinol <20.1 μg/dL
      • Inflammation: C-reactive protein >0.5 mg/dL or α-1-acid glycoprotein >1 g/L
      • Known malaria
  • Exposure
    • Anemia according to WHO Hb cutoffs
  • Study design
    • Survey-specific, pooled Hb fifth percentile cutoffs were estimated
    • Biomarker studies for tissue iron deficiency: Soluble transferrin receptor (sTfR), which reflects iron-deficient erythropoiesis
    • Among individuals with Hb and sTfR data, Hb-for-sTfR curve analysis was conducted to identify Hb inflection points that reflect tissue iron deficiency and increased erythropoiesis induced by anemia

RESULTS:

  • Healthy children: 12,445 | Healthy women: 25,880
    • Children mean (SD) age: 32.9 (16.0) months | 50.2% boys
    • Women mean (SD) age: 31.0 (9.5) years
  • Survey-specific Hb fifth percentile rages
    • Among children
      • Low: 7.90 g/dL (95% CI, 7.54 to 8.26 g/dL) in Pakistan
      • High: 11.23 g/dL (95% CI, 11.14 to 11.33 g/dL) in the US
    • Among women
      • Low: 8.83 g/dL (95% CI, 7.77 to 9.88 g/dL) in Gujarat, India
      • High: 12.09 g/dL (95% CI, 12.00 to 12.17 g/dL) in the US
  • Intersurvey variance around the Hb fifth percentile was low, supporting use of pooled data
    • For children: 3.6%
    • For women: 3.5%
  • Pooled fifth percentile estimates (low)
    • For children: 9.65 g/dL (95% CI, 9.26 to 10.04 g/dL)
    • For women: 10.81 g/dL (95% CI, 10.35 to 11.27 g/dL)
  • The Hb-for-sTfR curve demonstrated curvilinear associations with sTfR inflection points occurring at
    • Among children: Hb of 9.61 g/dL (95% CI, 9.55 to 9.67 g/dL)
    • Among women: 11.01 g/dL (95% CI, 10.95 to 11.09 g/dL)

CONCLUSION:

  • Current WHO cutoffs for determining anemia are higher than the pooled fifth percentile of Hb levels among healthy women and preschool children
  • Multinational estimates of Hb fifth percentile were 1.35 and 1.19 g/dL lower than the current WHO Hb cutoffs
  • Use of sTfR biomarker reinforced the fifth percentile data calculations
  • The authors conclude

Future studies focusing on Hb thresholds associated with functional and clinical health outcomes will improve the understanding of overall disease burden

Until then, revising Hb cutoff level definitions according to pooled multinational data could be considered 

Learn More – Primary Sources:

Evaluation of Hemoglobin Cutoff Levels to Define Anemia Among Healthy Individuals

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Maternal Anemia and Adverse Perinatal Outcomes
RCT Results: Single-Unit or Multiple Unit Blood Transfusion for Stable Postpartum Anemia?
Your Anemia Screening Test Fits in Your Pocket

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site